Terms: = Liver cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Prognosis
22 results:
1. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
[TBL] [Abstract] [Full Text] [Related]
3. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
4. Anterior gradient 2-derived peptide upregulates major histocompatibility complex class I-related chains A/B in hepatocellular carcinoma cells.
Bian J; He L; Wu Y; Liu W; Ma H; Sun M; Yu J; Yu Z; Wei M
Life Sci; 2020 Apr; 246():117396. PubMed ID: 32035130
[TBL] [Abstract] [Full Text] [Related]
5. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy.
Guo H; Xu M; Cao Z; Li W; Chen L; Xie X; Wang W; Liu J
Mol Pharm; 2020 Feb; 17(2):541-553. PubMed ID: 31876426
[TBL] [Abstract] [Full Text] [Related]
6. Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma.
Zeng YR; Yang QH; Liu QY; Min J; Li HG; Liu ZF; Li JX
World J Gastroenterol; 2019 Apr; 25(16):1986-1996. PubMed ID: 31086466
[TBL] [Abstract] [Full Text] [Related]
7. Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: a potential mechanism by which hepatitis D virus downregulates glutathione S-transferase P1 and induces liver injury and hepatocarcinogenesis.
Chen M; Du D; Zheng W; Liao M; Zhang L; Liang G; Gong M
Biochem Cell Biol; 2019 Apr; 97(2):130-139. PubMed ID: 30153423
[TBL] [Abstract] [Full Text] [Related]
8. New Staging System for Colorectal cancer Patients with Synchronous Peritoneal Metastasis in Accordance with the Japanese Classification of Colorectal Carcinoma: A Multi-Institutional Study.
Noura S; Ohue M; Ito Y; Miyoshi N; Kobayashi H; Kotake K; Sugihara K
Dig Surg; 2016; 33(1):66-73. PubMed ID: 26618448
[TBL] [Abstract] [Full Text] [Related]
9. Glutathione S-transferase P1 gene rs4147581 polymorphism predicts overall survival of patients with hepatocellular carcinoma: evidence from an enlarged study.
Wang Z; Qu K; Niu W; Lin T; Xu X; Huang Z; Liu S; Liu S; Chang H; Liu Y; Dong X; Liu C; Zhang Y
Tumour Biol; 2016 Jan; 37(1):943-52. PubMed ID: 26260272
[TBL] [Abstract] [Full Text] [Related]
10. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis.
Kobayashi H; Kotake K; Funahashi K; Hase K; Hirata K; Iiai T; Kameoka S; Kanemitsu Y; Maeda K; Murata A; Ohue M; Shirouzu K; Takahashi K; Watanabe T; Yano H; Yatsuoka T; Hashiguchi Y; Sugihara K;
J Gastroenterol; 2014 Apr; 49(4):646-54. PubMed ID: 23793379
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.
Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J
J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806
[TBL] [Abstract] [Full Text] [Related]
12. Factors influencing outcome after surgery for stage IV colorectal cancer.
Hotokezaka M; Jimi S; Hidaka H; Ikeda T; Uchiyama S; Nakashima S; Tsuchiya K; Chijiiwa K
Surg Today; 2008; 38(9):784-9. PubMed ID: 18751942
[TBL] [Abstract] [Full Text] [Related]
13. Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Tsai JF; Chuang LY; Ho MS; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Chang JG
Medicine (Baltimore); 2008 Mar; 87(2):87-98. PubMed ID: 18344806
[TBL] [Abstract] [Full Text] [Related]
14. Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis.
Oshima T; Kawasaki T; Ohashi R; Hasegawa G; Jiang S; Umezu H; Aoyagi Y; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2007 Feb; 57(2):82-90. PubMed ID: 17300672
[TBL] [Abstract] [Full Text] [Related]
15. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract] [Full Text] [Related]
16. Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.
Tang SH; Yang DH; Huang W; Zhou M; Zhou HK; Lu XH; Ye G
Cancer Detect Prev; 2006; 30(2):192-203. PubMed ID: 16697535
[TBL] [Abstract] [Full Text] [Related]
17. [Evaluation of peritoneal cytology in colorectal carcinoma].
Hasegawa K; Maruyama M; Maruyama S; Tamura N; Miyawaki Y; Takashima I; Koide A; Ebuchi M; Sakoma T
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1701-6. PubMed ID: 16315914
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical significance of washing cytology in patients with advanced gastric cancer].
Yabusaki H; Nakagawa S; Nashimoto A
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1643-5. PubMed ID: 16315895
[TBL] [Abstract] [Full Text] [Related]
19. Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma.
Cui J; Dong BW; Liang P; Yu XL; Yu DJ
World J Gastroenterol; 2005 May; 11(20):3027-33. PubMed ID: 15918184
[TBL] [Abstract] [Full Text] [Related]
20. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.
Fantappiè O; Masini E; Sardi I; Raimondi L; Bani D; Solazzo M; Vannacci A; Mazzanti R
Hepatology; 2002 Apr; 35(4):843-52. PubMed ID: 11915030
[TBL] [Abstract] [Full Text] [Related]
[Next]
